| Medical and Health Sciences | Lifetime | 182 | CA 7 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 51 | CA 4 | 99.95 |
| Epidemiology | Lifetime | 47 | CA 2 | 99.92 |
| Surgery | Lifetime | 92 | CA 7 | 99.92 |
| Pulmonary and Respiratory Medicine | Lifetime | 88 | CA 8 | 99.88 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 167 | CA 4 | 99.59 |
| History of Science, Technology and Medicine | Lifetime | 398 | CA 16 | 98.17 |
| Rheumatology | Lifetime | 675 | CA 32 | 96.62 |
| Emergency Medicine | Lifetime | 839 | CA 55 | 90.14 |
| Nephrology | Lifetime | 995 | CA 44 | 79.86 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 708 | CA 45 | 87.02 |
| Cardiac Structural Anomalies and Repair | Lifetime | 4 | CA 1 | 99.95 |
| Coronary Artery Anomalies | Lifetime | 2 | CA 1 | 99.92 |
| Cardiac tumors and thrombi | Lifetime | 6 | CA 1 | 99.89 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 8 | CA 2 | 99.94 |
| Aortic Disease and Treatment Approaches | Lifetime | 13 | CA 4 | 99.87 |
| Cardiac Valve Diseases and Treatments | Lifetime | 23 | CA 3 | 99.94 |
| Cardiovascular Effects of Exercise | Lifetime | 12 | CA 1 | 99.86 |
| Congenital Heart Disease Studies | Lifetime | 17 | CA 2 | 99.84 |
| Cardiomyopathy and Myosin Studies | Lifetime | 18 | CA 1 | 99.80 |
| Pericarditis and Cardiac Tamponade | Lifetime | 4 | CA 1 | 99.74 |
| Vascular anomalies and interventions | Lifetime | 12 | CA 1 | 99.67 |
| Cardiovascular Disease and Adiposity | Lifetime | 34 | CA 1 | 99.73 |
| Cardiac Imaging and Diagnostics | Lifetime | 115 | CA 3 | 99.78 |
| Cardiovascular Function and Risk Factors | Lifetime | 109 | CA 4 | 99.77 |
| Biomarkers in Disease Mechanisms | Lifetime | 9 | CA 2 | 99.22 |
| Medical Imaging and Pathology Studies | Lifetime | 69 | CA 3 | 99.41 |
| Cardiovascular Issues in Pregnancy | Lifetime | 41 | CA 3 | 99.37 |
| Acute Myocardial Infarction Research | Lifetime | 108 | CA 6 | 99.63 |
| Viral Infections and Immunology Research | Lifetime | 108 | CA 4 | 99.03 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 44 | CA 4 | 99.15 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 80 | CA 5 | 98.92 |
| Eosinophilic Disorders and Syndromes | Lifetime | 102 | CA 1 | 98.99 |
| Cardiac Arrhythmias and Treatments | Lifetime | 271 | CA 17 | 99.20 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 209 | CA 11 | 98.71 |
| Kawasaki Disease and Coronary Complications | Lifetime | 52 | CA 5 | 98.30 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 385 | CA 21 | 98.93 |
| Lipoproteins and Cardiovascular Health | Lifetime | 244 | CA 15 | 98.84 |
| Streptococcal Infections and Treatments | Lifetime | 226 | CA 11 | 98.46 |
| Trauma Management and Diagnosis | Lifetime | 152 | CA 10 | 98.56 |
| Coronary Interventions and Diagnostics | Lifetime | 359 | CA 15 | 98.93 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 918 | CA 66 | 98.32 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 240 | CA 6 | 96.98 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 987 | CA 83 | 97.83 |
| Aortic aneurysm repair treatments | Lifetime | 560 | CA 15 | 97.16 |
| Mechanical Circulatory Support Devices | Lifetime | 913 | CA 40 | 96.80 |
| Transplantation: Methods and Outcomes | Lifetime | 725 | CA 39 | 96.74 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 849 | CA 44 | 96.38 |
| Cardiovascular and Diving-Related Complications | Lifetime | 358 | CA 25 | 95.58 |
| Aortic Thrombus and Embolism | Lifetime | 59 | CA 5 | 94.04 |
| Infectious Aortic and Vascular Conditions | Lifetime | 293 | CA 9 | 95.62 |
| Cardiovascular Conditions and Treatments | Lifetime | 238 | CA 18 | 94.09 |
| Health and Medical Research Impacts | Lifetime | 494 | CA 40 | 91.56 |
| Syphilis Diagnosis and Treatment | Lifetime | 507 | CA 33 | 92.38 |
| Connective tissue disorders research | Lifetime | 846 | CA 32 | 92.42 |
| Williams Syndrome Research | Lifetime | 70 | CA 5 | 92.36 |
| Vasculitis and related conditions | Lifetime | 929 | CA 27 | 92.81 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 579 | CA 37 | 90.88 |
| Academic Writing and Publishing | Lifetime | 71 | CA 11 | 89.05 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 294 | CA 7 | 88.97 |
| Vascular Anomalies and Treatments | Lifetime | 717 | CA 33 | 85.57 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 797 | CA 27 | 88.66 |
| Infectious Aortic and Vascular Conditions | 2021-2025 | 674 | CA 10 | 58.80 |